Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atropine 0.01% for Myopia in Omani Children
NCT03508817Phase 1Unknown
- Sponsor
- Sultan Qaboos University
- Start
- Dec 2018
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of Myopine in myopia (2 arms), sponsored by Sultan Qaboos University. Primary endpoint: Progression of Myopia (Change in Spherical Equivalent Refractive Error) at 2 years. Status: unknown.
02
Drugs
Myopine
03
Conditions
myopia
Beyond the preview
Go deeper on NCT03508817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03508817.